Single‐cell transcriptome analysis further revealed that loss of CD300ld significantly alters the pro‐ and anti‐tumour cell composition and the related immune pathways, remodelling the TME from immune suppressive to immune active. This evidence concerns the gene CD300LD and neoplasm.